Tyra biosciences to present at upcoming investor conferences

Carlsbad, calif. , may 23, 2024 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in fibroblast growth factor receptor (fgfr) biology, today announced that company management will participate in the following investor conferences: td cowen's 5th annual oncology innovation summit: insights for asco & eha, may 28-29, 2024 : todd harris, ceo of tyra, will participate in a fireside chat on tuesday, may 28, 2024, at 1:00 pm et.
TYRA Ratings Summary
TYRA Quant Ranking